Lv4
750 积分 2024-03-05 加入
An engineered viral protein activates STAT5 to prevent T cell suppression
1个月前
已完结
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer
1个月前
已完结
Comparison of predictability for human pharmacokinetics parameters among monkeys, rats, and chimeric mice with humanised liver
2个月前
已完结
PILRα on tumor cells interacts with the T cell surface protein CD99 to suppress antitumor immunity
2个月前
已完结
Structure-Activity Studies of Interleukin-2
3个月前
已完结
T cell activation and effector function in the human Jurkat T cell model
3个月前
已完结
Integrating immunotherapy in the treatment of resectable gastric cancer: Are we on the right track?
3个月前
已完结
Functional differences between rodent and human PD-1 linked to evolutionary divergence
3个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
4个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
4个月前
已完结
皖公网安备34019202002308
